Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma - ready for their use? Authors' reply.

Danta, Mark; Tan, Regina Zi Hwei; Lockart, Ian; Abdel Shaheed, Christina

Danta, Mark; Tan, Regina Zi Hwei; Lockart, Ian; Abdel Shaheed, Christina.

Afiliación

Danta M; St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.
Tan RZH; Faculty of Medicine and Health, St Vincent's Clinical School, UNSW, Sydney, NSW, Australia.
Lockart I; Department of Gastroenterology and Hepatology, St Vincent's Hospital, Sydney, NSW, Australia.
Abdel Shaheed C; Faculty of Medicine and Health, St Vincent's Clinical School, UNSW, Sydney, NSW, Australia.

Aliment Pharmacol Ther ; 54(6): 852-853, 2021 09.

Article en En | MEDLINE | ID: mdl-34425011

Asunto(s)

Carcinoma Hepatocelular; Neoplasias Hepáticas; Antiinflamatorios no Esteroideos/uso terapéutico; Aspirina/uso terapéutico; Carcinoma Hepatocelular/epidemiología; Carcinoma Hepatocelular/prevención & control; Quimioprevención; Humanos; Neoplasias Hepáticas/epidemiología; Neoplasias Hepáticas/prevención & control

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: Aliment Pharmacol Ther Asunto de la revista: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google